Spanish researchers have created a powerful new open-source tool that helps uncover the hidden genetic networks driving ...

With an estimated more than 10 million cases, India accounts for nearly 20% of the global epilepsy burden. The number of ...

ALS is a debilitating paralytic disease characterized as the death of upper and lower motor neurons. Fortunately, ALS is ...

Whole Genome Amplification (WGA) offers vast opportunities in personalized medicine, cancer research, and reproductive health ...

Separate studies led by scientists at Dartmouth Hitchcock Medical Center (DMHC) and Queens University offer some clarity about the hidden causes of recurrent pregnancy loss. Data from both studies is ...

Study of 99 pediatric patients found clinically significant CNVs in 30% of cases, supporting CMA as a first-tier test for developmental delay and ID. Clinically significant CNVs were identified in 30% ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

Designation highlights GeneDx innovation in clinical whole genome and whole exome testing and accelerates the pathway for FDA authorization of these novel diagnostic tests GeneDx (Nasdaq: WGS), a ...

A structural aberration (SA) with secondary implications (SASIs) involving a cancer susceptibility gene is identified on chromosome microarray in approximately 0.6% tests performed on index cases.

Abstract: Breast cancer subtyping presents a significant clinical and scientific challenge. The prevalent expression-based Prediction Analysis of the Microarray of 50 genes (PAM50) system and its ...